Tag: göteborgbio

Bilder

Karin Ekström

2012-05-30 19:43 GöteborgBIO Karin Ekström, BIOMATCELL

Erik Forsberg, Managing Director, Uppsala BIO

2012-03-20 09:39 GöteborgBIO Erik Forsberg, Managing Director, Uppsala BIO

BIO-X

2012-03-20 09:30 GöteborgBIO Uppsala BIO och GöteborgBIO har ingått ett samarbetsavtal som ska intensifiera ansträngningarna med att överbrygga gapet mellan grundforskning, klinisk tillämpning och industriell produktutveckling. Samarbetet gäller BIO-X, den modell för öppen innovation som Uppsala BIO utvecklat framgångsrikt under flera år, som nu också blir tillgänglig för forskare i hela Västra Götalandsregionen.

Lena Blomberg, arbetande styrelseordförande och processledare, GöteborgBIO

2012-03-16 17:51 Uppsala BIO

Immunicum enrolls the first patient in its COMBIG clinical phase I/II-trial in renal cell carcinoma.

2012-03-12 09:26 GöteborgBIO In total, 12 patients with metastasis cancer of the kidney are being treated in order to investigate possible side effects and the antitumour effect of the vaccine. "“We are looking forward to the study and hope that a future kidney cancer vaccine will help a large number of people that cannot be effectively helped today," says Jamal El-Mosleh, Immunicum´s CEO.

Professor Suchitra Holgersson

2012-01-03 12:13 GöteborgBIO Professor Suchitra Holgersson

Medfield Diagnostics AB,  StrokefinderR10 on patient

2011-11-18 11:49 GöteborgBIO Medfield's first product, Strokefinder R10, is an instrument for researchers within stroke and neurological research. It is versatile and can be used both for snapshot measurements to differentiate between ischemic (blood clot) and hemorrhagic stroke (bleeding in brain tissue) as well as to monitor changes over time.

Lena Blomberg

2011-05-25 15:07 GöteborgBIO Lena Blomberg, executive chairperson as well as Process Manager for GöteborgBIO as of May 16, 2011.

Maud Olofsson tries the Strokefinder R10

2011-05-17 16:41 GöteborgBIO Medfield Diagnostics is developing the diagnostic instrument Strokefinder R10, a helmet that uses microwaves to quickly determine whether a patient has been affected by a clot or haemorrhage in the brain. During a visit in Göteborg, Maud Olofsson, the Swedish Minister for Enterprise and Energy, did not hesitate to try it on.

Nanofabrication Laboratory MC2, Chalmers, Göteborg

2011-02-06 14:46 GöteborgBIO Chalmers MC2 Nanofabrication Laboratory- bild 1